Oct 24 (Reuters) - Healthpeak Properties raised the lower-end of its annual funds from operations (FFO) forecast on Thursday, banking on steady demand for its medical office and life science properties.
The U.S. healthcare-centric company now expects its 2024 adjusted FFO, a key performance measure for real estate investment trusts, to be in the range of $1.79 to $1.81 per share, compared to its previous estimate of $1.77 to $1.81 per share.
Analysts, on average, were expecting adjusted FFO of $1.79 per share, as per data compiled by LSEG.
Demand for the outpatient & life science sites owned by the company has benefited from a rise in patient visits, creating a favorable leasing environment.
The Denver, Colorado-based firm posted adjusted FFO of 45 cents per share in the third quarter, largely in line with analysts' estimate of 44 cents per share.
The company reported total revenue of $700.40 million for the quarter ended Sept. 30, beating estimates of $680.25 million.
The REIT owns medical office and life science assets, as well as senior housing, hospital and post-acute care assets.
Healthpeak's lab portfolio is mainly concentrated in San Francisco and San Diego, California, as well as in Boston, Massachusetts.
(Reporting by Sneha S K; editing by Alan Barona) ((mailto:Sneha.SK@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。